Vera Therapeutics, Inc.

VERA Healthcare Biotechnology

EPS
−26.7%
Free cash flow
−82.5%
Total debt
+1.03%

Quarter to June 2026, against a year earlier

29.85 0.29 −0.96%
Market cap
$2.2B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Total current assets
728.88 651.22 172.02 125.70 82.54 54.26 3.57
Total non-current assets
5.85 4.46 3.52 5.74 1.21 0.29 1.82
Total Assets
734.73 655.68 175.55 131.44 83.75 54.55 5.38
Total current liabilities
53.46 25.37 22.30 25.60 7.69 2.41 1.06
Total non-current liabilities
76.76 53.16 51.56 28.93 6.47 1.92 0.77
Total liabilities
130.21 78.53 73.86 54.53 14.16 4.33 1.83
Common Equity (Total)
604.52 577.16 101.69 76.91 69.59 (89.35) (36.55)
Shareholders Equity (Total)
604.52 577.16 101.69 76.91 69.59 50.23 3.55
Total Debt
74.84 50.69 49.88 24.81 4.92 0.00 0.01

Show all line items

In millions of $ except per-share values · columns are period end dates